Royal Society of Chemistry, MedChemComm, 4(6), p. 547-554
DOI: 10.1039/c4md00564c
Full text: Unavailable
Over the past fifteen years, we reported the design and synthesis of different series of compounds targeting the C1 domain of protein kinase C (PKC) that were based on various templates.